CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

Clinical trial NCT06593145 · RECRUITING

Trial details

NCT number: NCT06593145
Sponsor: FamiCordTx
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Mantle Cell Lymphoma (MCL)Large B-cell Lymphoma

Start date: 2023-05-24
Primary completion: 2025-06-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.